Conclusions
T1D, T2D, hypoglycemic, diabetes
EVENTS, TYPE 1 DIABETES, TYPE 2 DIABETES, DIABETES
Non‐adjunctive use of the Dexcom G6 CGM system improved glycaemic control and was safe for adults using IIT.ANSHIN is a single‐arm, prospective, interventional study that assessed the impact of non‐adjunctive Dexcom G6 continuous glucose monitoring (CGM) in adults with diabetes using intensive insulin therapy. After initiating CGM use, severe hypoglycemic events decreased and mean HbA1c decreased by 1.3, 1.0, and 1.0 percentage points for participants with type 1 diabetes (T1D), type 2 diabetes (T2D), or age ≥65, respectively (
Members of the ANSHIN Study Group are listed in the Acknowledgements.